Company intelligence
One Health Company
One Health Company is the parent company behind FidoCure®, the personalized therapeutics engine for canine cancer.
About One Health Company
FidoCure® is an AI-driven personalized therapeutics engine for canine cancer, developed by One Health Company. Leveraging the genetic similarities between canine and human cancers, FidoCure combines genomic, clinical, and real-world evidence to help veterinarians make more informed, individualized treatment decisions. Through its proprietary next-generation DNA sequencing test, FidoCure has built the world’s largest canine cancer genomics dataset, enabling more effective and accessible targeted therapies. FidoCure’s work has been published in Nature Precision Oncology and Nature Scientific Reports. Backed by leading biotech investors including Polaris Ventures, Andreessen Horowitz (a16z), and Y Combinator, FidoCure is advancing personalized cancer care for dogs while generating insights relevant to human health.
Verified activity
Signals from One Health Company
2 published signals
Partnerships
One Health Company partnered with partners and investors including Y Combinator, Andreessen Horowitz, and Polaris Partners to treat over 7,000 dogs through FidoCure.
Reported by One Health Company
Products & Services
One Health Company launched its FidoCure precision medicine platform to transform canine cancer care for all future dogs.
Reported by Christina Lopes